AU2002230911A1 - Signal-1/signal-2 bifunctional peptide inhibitors - Google Patents

Signal-1/signal-2 bifunctional peptide inhibitors

Info

Publication number
AU2002230911A1
AU2002230911A1 AU2002230911A AU3091102A AU2002230911A1 AU 2002230911 A1 AU2002230911 A1 AU 2002230911A1 AU 2002230911 A AU2002230911 A AU 2002230911A AU 3091102 A AU3091102 A AU 3091102A AU 2002230911 A1 AU2002230911 A1 AU 2002230911A1
Authority
AU
Australia
Prior art keywords
chain
signal
moiety
immune response
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230911A
Other languages
English (en)
Inventor
Yongbo Hu
Joseph S. Murray
Teruna J Siahaan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas
Original Assignee
University of Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas filed Critical University of Kansas
Publication of AU2002230911A1 publication Critical patent/AU2002230911A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002230911A 2000-12-18 2001-12-17 Signal-1/signal-2 bifunctional peptide inhibitors Abandoned AU2002230911A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/739,466 US7786257B2 (en) 2000-12-18 2000-12-18 Signal-1/signal-2 bifunctional peptide inhibitors
US09/739,466 2000-12-18
PCT/US2001/048632 WO2002050250A2 (en) 2000-12-18 2001-12-17 Signal-1/signal-2 bifunctional peptide inhibitors

Publications (1)

Publication Number Publication Date
AU2002230911A1 true AU2002230911A1 (en) 2002-07-01

Family

ID=24972431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230911A Abandoned AU2002230911A1 (en) 2000-12-18 2001-12-17 Signal-1/signal-2 bifunctional peptide inhibitors

Country Status (8)

Country Link
US (1) US7786257B2 (cg-RX-API-DMAC7.html)
EP (2) EP1932539A3 (cg-RX-API-DMAC7.html)
JP (1) JP2004536783A (cg-RX-API-DMAC7.html)
AT (1) ATE400293T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002230911A1 (cg-RX-API-DMAC7.html)
CA (1) CA2432767A1 (cg-RX-API-DMAC7.html)
DE (1) DE60134791D1 (cg-RX-API-DMAC7.html)
WO (1) WO2002050250A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188218B2 (en) 2006-10-27 2012-05-29 University Of Kansas Bi-functional peptides for multiple sclerosis treatment and diagnosis
US8735154B2 (en) 2006-10-30 2014-05-27 The University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
WO2008067281A1 (en) * 2006-11-30 2008-06-05 Vance Products Incorporated D/B/A Cook Urological Incorporated Removable handle for medical device
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
WO2009022155A2 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptide with reduced dimer formation
AU2008317331B2 (en) * 2007-10-25 2013-08-29 The Scripps Research Institute Antibody-mediated disruption of quorum sensing in bacteria
DE102009040716B4 (de) * 2009-09-10 2011-07-14 Miltenyi Biotec GmbH, 51429 Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen
EP2585096B1 (en) 2010-06-24 2021-05-05 University Of Kansas Bifunctional conjugate compositions and associated methods
EP2736536A4 (en) 2011-07-27 2015-03-11 Univ Kansas TEMPLATE ISLAND CELLS AND SMALL ISLAND CELL PATTERNS FOR THE TREATMENT OF DIABETES
JP6126107B2 (ja) * 2011-10-18 2017-05-10 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ シリンガレシノールを含むｓｉｒｔ−１活性化剤
WO2018215506A1 (en) * 2017-05-23 2018-11-29 Université De Genève Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844095A (en) * 1991-06-27 1998-12-01 Bristol-Myers Squibb Company CTLA4 Ig fusion proteins
EP0576842B1 (de) * 1992-06-11 2002-10-16 MERCK PATENT GmbH Verfahren und Mittel zum Nachweis von Listerien
US5540926A (en) * 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation
JP4382163B2 (ja) 1997-03-27 2009-12-09 ザ カウンシル オブ ザ クイーンズランド インスティチュート オブ メディカル リサーチ ターゲッティング分子を用いた免疫応答の増強
AU1084901A (en) * 1999-10-14 2001-04-23 Martha S. Hayden-Ledbetter Dna vaccines encoding antigen linked to a domain that binds cd40

Also Published As

Publication number Publication date
WO2002050250A2 (en) 2002-06-27
JP2004536783A (ja) 2004-12-09
DE60134791D1 (de) 2008-08-21
WO2002050250A3 (en) 2004-01-08
US20050107585A1 (en) 2005-05-19
CA2432767A1 (en) 2002-06-27
EP1404362A2 (en) 2004-04-07
EP1404362B1 (en) 2008-07-09
EP1404362A4 (en) 2005-06-01
ATE400293T1 (de) 2008-07-15
EP1932539A2 (en) 2008-06-18
EP1932539A3 (en) 2008-10-29
US7786257B2 (en) 2010-08-31

Similar Documents

Publication Publication Date Title
AU2002230911A1 (en) Signal-1/signal-2 bifunctional peptide inhibitors
SE8703012D0 (sv) Retainer for glove
WO2004083251A3 (en) Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
DK163434C (da) Enzymatisk detergentadditiv og detergentkomposition indeholdende dette
PT891428E (pt) Sub-unidade catalitica fosfatidilinositol 3-cinase p110 delta
ZA907079B (en) Novel peptidase and isomerase inhibitors
CA2000342A1 (en) Novel peptidase inhibitors
BE905918A (fr) Maillon pour une chaine de recueillement de produits.
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DE68927630D1 (de) Analoge von Peptrolsubstraten
TR199700699T1 (en) Bas�n� g�stergesi.
DK431189D0 (da) Peptidaseinhibitorer
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
DE69233666D1 (de) Verzweigte Peptide zum Nachweis von Antikörpern
GB2262528B (en) Further improvements relating to the radiolabelling of proteins
DK0994187T3 (da) Renin-aktivt stof omfattende humant prorenin og antistoffer mod prorenin-profragmentet
DK1041461T3 (da) Armbåndsur
DE59903388D1 (de) Schubrostanordnung für einen Festbrennstoff-Kessel o. dgl.
NZ235411A (en) Antibodies produced to highly conserved amino acid sequences of insulin
DE69840438D1 (en) Antigen
IT1269447B (it) Bruciatore di gas
KR890009274U (ko) 다목적 휴대용 브린넬 경도기
HUT70287A (en) Mv koma variety of early wheat (triticum aestivum l.)
SE9802170L (sv) Tillbehör till färdskrivare
ES1015770U (es) Un cinturon.